Nobel Laureate Dies

Richard Heck, pioneer of a reaction that binds carbon atoms using palladium, has passed away at age 84.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

UNIVERSITY OF DELAWARE

Richard Heck, a 2010 winner of the Nobel Prize in Chemistry, died earlier this month (October 9) in a Manila, Philippines hospital, following years of illness, Reuters reported. He was 84.

Heck earned his bachelor’s and doctorate degrees at the University of California, Los Angeles, in the 1950s. As a faculty member at the University of Delaware, he discovered the eponymous “Heck reaction,” which connects carbon atoms using a metal called palladium. The discovery impacted DNA sequencing, drug discoveries, and the electronics industry. Heck shared the 2010 chemistry Nobel with two other chemists; all three were recognized for their work on carbon atom linkages.

“Almost every pharmaceutical that is made today is made using these organo-palladium couplings,” Douglass Taber, a chemist at the University of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Karen Zusi

    This person does not yet have a bio.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development